Scarica l'app Stockscreener
1.40
7.69%
0.10
Rani Therapeutics Holdings Inc Azioni (RANI) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
4.47%
14.03
|
13.43 | 17.86 | 18.29 | 16.52 |
| Interest Income/Expense |
0.15%
1.294
|
1.296 | 1.316 | 1.266 | 1.207 |
| Depreciation and Amortization |
9.25%
0.248
|
0.227 | 0.218 | 0.189 | 0.188 |
| Operating Income/Loss |
4.47%
-14.03
|
-13.43 | -17.86 | -18.29 | -16.52 |
| Income/Loss From Continuing Operations Before Tax |
5.15%
-14.78
|
-14.05 | -18.33 | -18.66 | -16.83 |
| Income/Loss From Continuing Operations After Tax |
5.15%
-14.78
|
-14.05 | -18.33 | -18.66 | -16.83 |
|
Net Income/Loss
|
5.15%
-14.78
|
-14.05 | -18.33 | -18.66 | -16.83 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
4.87%
-7.296
|
-6.957 | -9.135 | -9.361 | -8.46 |
| Basic Average Shares |
202.68%
26.03
|
-25.35 | 25.55 | 25.34 | 25.24 |
| Diluted Average Shares |
202.68%
26.03
|
-25.35 | 25.55 | 25.34 | 25.24 |
| Basic Earnings Per Share |
87.87%
-0.29
|
-2.39 | 0.36 | 0.37 | 0.33 |
| Diluted Earnings Per Share |
87.87%
-0.29
|
-2.39 | 0.36 | 0.37 | 0.33 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):